GENEVA – The World Health Organization says isolated cases of drug-resistant swine flu in Britain and the United States have not changed the agency’s assessment of the disease. It says Tamiflu remains highly effective against the vast majority of H1N1 cases. Four cancer patients in a North Carolina hospital tested positive last week for a type of [...]
Continue reading...14. November 2009
CSL Limited’s H1N1 influenza vaccine has been approved by the U.S. Food and Drug Administration to include children 6 months and older, the agency said. Previously, the shot had been approved only for adults. The vaccine is subject to the same manufacturing and testing oversight as seasonal flu vaccines, the agency said in a news release. [...]
Continue reading...11. August 2009
Using oseltamivir, marketed as Tamiflu, early in the course of the flu reduces complications and hospitalizations in children and adolescents with chronic medical conditions such as asthma, according to a new study. Using anonymous data from MarketsSan databases (Thomson Reuters, Cambridge, Massachusetts), Dr. Pedro A. Piedra from Baylor College of Medicine, Houston and colleagues studied 1634 [...]
Continue reading...26. July 2009
LONDON – In a drive to inoculate people against swine flu before winter, many European governments say they will fast-track the testing of a vaccine, arousing concern among some experts about safety and proper doses. The European Medicines Agency, the EU’s top drug regulatory body, is accelerating the approval process for swine flu vaccine, and countries [...]
Continue reading...29. April 2009
UMBAI (AFP) – Indian drug manufacturer Cipla Tuesday said it could supply 1.5 million doses of a copy of the Tamiflu antiviral medication to fight the international swine flu outbreak. “We have already received proposals from people on behalf of countries in Latin America, Mexico and Israel,” the Mumbai-based company’s chief executive and joint managing director, [...]
Continue reading...
26. November 2009
0 Comments